117 related articles for article (PubMed ID: 1850910)
21. Primer-terminus stabilization at the 3'-5' exonuclease active site of phi29 DNA polymerase. Involvement of two amino acid residues highly conserved in proofreading DNA polymerases.
de Vega M; Lazaro JM; Salas M; Blanco L
EMBO J; 1996 Mar; 15(5):1182-92. PubMed ID: 8605889
[TBL] [Abstract][Full Text] [Related]
22. Characterization of purified Epstein--Barr virus induced deoxyribonucleic acid polymerase: nucleotide turnover, processiveness, and phosphonoacetic acid sensitivity.
Grossberger D; Clough W
Biochemistry; 1981 Jul; 20(14):4049-55. PubMed ID: 6269579
[TBL] [Abstract][Full Text] [Related]
23. Distinctive properties of DNA polymerases induced by herpes simplex virus type-1 and Epstein-Barr virus.
Allaudeen HS
Antiviral Res; 1985 Feb; 5(1):1-12. PubMed ID: 2984987
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of the 3'-to-5' exonuclease activity associated with Epstein-Barr virus DNA polymerase by ribonucleoside 5'-monophosphates.
Tsurumi T
Virology; 1992 Aug; 189(2):803-7. PubMed ID: 1322605
[TBL] [Abstract][Full Text] [Related]
25. A monoclonal antibody that neutralizes Epstein-Barr virus, human cytomegalovirus, human herpesvirus 6, and bacteriophage T4 DNA polymerases.
Tsai CH; Williams MV; Glaser R
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7963-7. PubMed ID: 1700422
[TBL] [Abstract][Full Text] [Related]
26. The bacteriophage phi 29 DNA polymerase, a proofreading enzyme.
Garmendia C; Bernad A; Esteban JA; Blanco L; Salas M
J Biol Chem; 1992 Feb; 267(4):2594-9. PubMed ID: 1733957
[TBL] [Abstract][Full Text] [Related]
27. DNA polymerase III from Saccharomyces cerevisiae. I. Purification and characterization.
Bauer GA; Heller HM; Burgers PM
J Biol Chem; 1988 Jan; 263(2):917-24. PubMed ID: 3275661
[TBL] [Abstract][Full Text] [Related]
28. The 3'-5' exonuclease of human DNA polymerase delta (pol delta) is regulated by pol delta accessory factors and deoxyribonucleoside triphosphates.
Lee SH
Nucleic Acids Res; 1993 Apr; 21(8):1935-9. PubMed ID: 8098524
[TBL] [Abstract][Full Text] [Related]
29. An error-correcting proofreading exonuclease-polymerase that copurifies with DNA-polymerase-alpha-primase.
Bialek G; Grosse F
J Biol Chem; 1993 Mar; 268(8):6024-33. PubMed ID: 8383685
[TBL] [Abstract][Full Text] [Related]
30. Specific immune serum to the Epstein-Barr virus DNA polymerase.
Petit RG; Leung K; Shaw JE
J Virol; 1987 Oct; 61(10):3331-4. PubMed ID: 3041054
[TBL] [Abstract][Full Text] [Related]
31. Purification of Autographa californica nucleopolyhedrovirus DNA polymerase from infected insect cells.
Hang X; Guarino LA
J Gen Virol; 1999 Sep; 80 ( Pt 9)():2519-2526. PubMed ID: 10501509
[TBL] [Abstract][Full Text] [Related]
32. Induction of DNA polymerase activity after superinfection of Raji cells with Epstein-Barr virus.
Feighny RJ; Henry BE; Datta AK; Pagano JS
Virology; 1980 Dec; 107(2):415-23. PubMed ID: 6256941
[No Abstract] [Full Text] [Related]
33. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
Dyson OF; Pagano JS; Whitehurst CB
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells.
Ooka T; Lenoir GM; Decaussin G; Bornkamm GW; Daillie J
J Virol; 1986 May; 58(2):671-5. PubMed ID: 3009879
[TBL] [Abstract][Full Text] [Related]
35. Processive proofreading by the adenovirus DNA polymerase. Association with the priming protein reduces exonucleolytic degradation.
King AJ; Teertstra WR; Blanco L; Salas M; van der Vliet PC
Nucleic Acids Res; 1997 May; 25(9):1745-52. PubMed ID: 9108156
[TBL] [Abstract][Full Text] [Related]
36. Purification of Epstein-Barr virus DNA polymerase from P3HR-1 cells.
Kallin B; Sternås L; Saemundssen AK; Luka J; Jörnvall H; Eriksson B; Tao PZ; Nilsson MT; Klein G
J Virol; 1985 May; 54(2):561-8. PubMed ID: 2985818
[TBL] [Abstract][Full Text] [Related]
37. Unique inhibitory effect of 1-(2'-deoxy-2'-fluoro-beta-L-arabinofuranosyl)-5-methyluracil 5'-triphosphate on Epstein-Barr virus and human DNA polymerases.
Kukhanova M; Lin ZY; Yas'co M; Cheng YC
Biochem Pharmacol; 1998 Apr; 55(8):1181-7. PubMed ID: 9719472
[TBL] [Abstract][Full Text] [Related]
38. The proofreading 3'-->5' exonuclease activity of DNA polymerases: a kinetic barrier to translesion DNA synthesis.
Khare V; Eckert KA
Mutat Res; 2002 Dec; 510(1-2):45-54. PubMed ID: 12459442
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity.
Tsai CH; Williams MV; Glaser R
Intervirology; 1990; 31(2-4):215-22. PubMed ID: 2165046
[TBL] [Abstract][Full Text] [Related]
40. Incorporation into DNA of the base analog 2-aminopurine by the Epstein-Barr virus-induced DNA polymerase in vivo and in vitro.
Grossberger D; Clough W
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7271-5. PubMed ID: 6278464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
